Interesting you brought up OpenAI. If the GF invested
Interesting you brought up OpenAI. If the GF invested $10billion with them, what are the possibilities that OpenAI is the 3rd party AI collaborator if they came on board 1 month prior to Scott Hansen's hire in March 2023. Remember, Scott Hansen was well recognized by the GF for his contribution to the VIR-1388 HIV vaccine, and when VIR exited the HIV vaccine trials, just a month later, Max was hired by both CytoDyn and the GF.
The 3rd party AI collaborator not only helped CytoDyn in HIV, but it also helped in MASH. Cyrus Arman was really keen about MASH/NASH at the time and it could have been because of data he saw coming from the 3rd party AI collaborator.
How was the combination of ART + bNAbs + leronlimab made? Did the 3rd party AI collaborator have anything to contribute?
17 different long acting leronlimab molecules? Did Scott just come up with all of them on his own?
LS mutation allows leronlimab to cross placenta barrier and who designed the mutation?
If the GF was with CytoDyn ever since March 2023, when the 3rd party AI collaborator came aboard, and all these HIV breakthroughs come out 2 years later, seems to me that the GF knew HIV Cure and PrEP was hidden inside the leronlimab.molecule and it just required an AI engine to find the secret.
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Security with the Fast Guard App Fast Guard Service, a prominent name in licensed security guard services, has introduced a cutting-edge solution for the construction and property management sectors. This newly enhanced Fast Guard App empowers users to swiftly order and manage essential security services, including fire watch and armed or unarmed guards,...
Continue Reading
China's Industrial Profits Accelerate in June China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase....
Continue Reading
CyberArk Celebrates a Decade Since Its IPO In a significant milestone, CyberArk, a leader in identity security, marks ten years since its Initial Public Offering (IPO) on the NASDAQ. This anniversary serves as a moment for reflection and highlights essential achievements throughout the company's growth. Ringing the NASDAQ Bell to Honor Their Journey On the day of the...
Continue Reading
Biosurgery Market Overview The global biosurgery market, currently valued at approximately US$14.96 billion, is expected to grow to a remarkable US$21.59 billion by a specified target year. This substantial growth, projected at an impressive CAGR of 6.4%, is fueled primarily by the urgent need for effective management of blood loss during surgical procedures and the rise...
Continue Reading
Overview of MIND Technology's Recent Performance MIND Technology, Inc. (NASDAQ: MIND) has recently unveiled its financial outcomes for the third quarter of fiscal 2026. The company achieved revenues amounting to approximately $9.7 million during this period. Comparative Revenue Analysis This figure reflects a notable decrease from the $13.6 million realized in the prior...
Continue Reading